VITROS® HIV Combo Test - Lab
Footnote

4 Centers for Disease Control and Prevention and Association of Public Health Laboratories. Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations. Available at http://stacks.cdc.gov/view/cdc/23447. Published June 27, 2014. 3 Mitchell E.O., Stewart G, Bajzik O, Ferret M, Bensten C, Shriver M.K. (2013). Performance comparison of the 4th generation Bio-Rad LaboratoriesGS HIV Combo Ag/Ab EIA on the EVOLISTMautomated system versusAbbott ARCHITECT HIV Ag/Ab Combo, Ortho Anti-HIV 1 + 2 EIA onVitros ECi and Siemens HIV-1/O/2 enhanced on Advia Centaur. Journal of Clinical Virology 58S (2013) e79– e84

Footnote

5 Serioconversion panel: Internal testing performed and data on file

VITROS® HIV Combo Test
A Critical Timeframe for Testing
The VITROS® HIV Combo Test, a 4th generation assay with class-leading p24 antigen sensitivity, is the clear choice.
A key priority remaining now is to get all labs on a 4th Generation HIV combo algorithm to shorten the window period. 4
CDC Guidelines

Sensitivity. Earlier Detection. Trust.

4th gen HIV combo test provide earlier detection because they test for a combination of antibodies: HIV-1, HIV-2, as well as the HIV p24 antigen which becomes detectable approximately 15 days or two weeks post-infection. That's seven to ten days earlier than previous tests-a critical time frame for prevention. 4 Rollover to learn more about our sensitivity, earlier detection and trust.
Sensitivity
Sensitivity

VITROS® HIV Combo test became reactive earlier for six of 32 seroconversion panels (agreement for 25 of 32 panels) when compared to a leading commercially available fourth-generation Ag/Ab test.5

Earlier Detection
Earlier Detection

The ability to detect HIV at the earliest bleed demonstrates superior test sensitivity and the ability to detect HIV infection earlier, which is critical in improving diagnosis, aiding prevention, and facilitating care for patients.

Trust

With class-leading antigen sensitivity that doesn't sacrifice specificity, VITROS® HIV Combo test gives you the utmost confidence in results.

Enhance your reliability and increase the trust

VITROS® Systems deliver operational simplicity and ease of use with random and STAT access, minimal need for operator interventions and excellent reagent stability. Reliable performance is enhanced by the VITROS® System Technology, designed to improve system reliability. Rollover to learn more.
VITROS® INTELLICHECK®
VITROS® INTELLICHECK®

technology monitors, verifies and documents diagnostics checks throughout sample assay processing. This prevents reporting of results that may be affected by exceptions.

VITROS® MicroWell
VITROS® MicroWell

technology combined with our Enhanced Chemiluminescence Detection Technology improves signal detection with outstanding precision and a wide dynamic range.

VITROS® MicroSensor
VITROS® MicroSensor

technology detects endogenous interferences and flags affected results without the use of reagents or extra consumables. This verifies the integrity of processed sample.

VITROS® VersaTip
VITROS® VersaTip

technology is designed to prevent sample carryover and cross-contamination using disposable tips (for samples and reagents on VITROS® 3600 lmmunodiagnostic System).

${loading}